Skin-lightening cream
Safety Gate Alert A12/00432/22 · Fairness
Risk description
The product contains hydroquinone (declared value 2% by weight) which can cause skin irritation and dermatitis. It also contains mometasone (declared value 0,10% by weight). Mometasone is a corticosteroid that should be made available only under medical prescription: exposure to it could cause skinirritation and may lead to endocrine problems. The product does not comply with the Cosmetic Products Regulation.
Measures taken
Type of economic operator taking notified measure(s): RetailerCategory of measure(s): Stop of salesDate of entry into force: Unknown